Jackson Creek Investment Advisors LLC Increases Stake in Tenet Healthcare Corporation $THC

Jackson Creek Investment Advisors LLC boosted its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 235.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 9,032 shares of the company’s stock after purchasing an additional 6,341 shares during the quarter. Jackson Creek Investment Advisors LLC’s holdings in Tenet Healthcare were worth $1,795,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of THC. NewEdge Advisors LLC grew its position in Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after purchasing an additional 166 shares during the last quarter. Jones Financial Companies Lllp increased its stake in shares of Tenet Healthcare by 299.1% in the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after purchasing an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC purchased a new stake in shares of Tenet Healthcare in the 2nd quarter worth $290,000. Quantbot Technologies LP purchased a new stake in shares of Tenet Healthcare in the 2nd quarter worth $65,000. Finally, Amundi increased its stake in shares of Tenet Healthcare by 4,207.8% in the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock worth $4,652,000 after purchasing an additional 26,383 shares in the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, EVP Paola M. Arbour sold 6,500 shares of the stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the transaction, the executive vice president owned 29,291 shares of the company’s stock, valued at $6,983,853.13. This represents a 18.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Thomas W. Arnst sold 24,000 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the transaction, the executive vice president directly owned 8,012 shares of the company’s stock, valued at $1,875,128.48. This trade represents a 74.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 46,517 shares of company stock valued at $10,943,111 in the last 90 days. Insiders own 0.97% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Morgan Stanley set a $254.00 price objective on Tenet Healthcare in a research note on Friday, May 1st. TD Cowen restated a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. KeyCorp cut their price target on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Finally, Robert W. Baird cut their price target on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a research note on Tuesday, May 5th. Nineteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $244.16.

Tenet Healthcare Trading Up 1.8%

Shares of THC stock opened at $176.92 on Wednesday. Tenet Healthcare Corporation has a 52-week low of $146.60 and a 52-week high of $247.21. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. The firm has a market capitalization of $15.24 billion, a PE ratio of 9.20, a PEG ratio of 1.14 and a beta of 1.30. The stock has a fifty day simple moving average of $192.04 and a two-hundred day simple moving average of $202.45.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. During the same quarter in the prior year, the business posted $4.36 EPS. Tenet Healthcare’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, analysts predict that Tenet Healthcare Corporation will post 17.67 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.